AI-generated summary
The authors reviewed 21 systematic reviews of photobiomodulation for chemo- and radiotherapy-induced oral mucositis and assessed their methodological quality. Most reviews were rated critically low or low quality, and the meta-analyses that were significant were mostly classified as weak in strength. The authors conclude that support for photobiomodulation's efficacy in chemotherapy-induced oral mucositis rests on low-quality evidence.
- Studies included
- 21
- Who or what was studied
- Patients undergoing chemotherapy and/or radiotherapy with oral mucositis, as evaluated in included systematic reviews
- Limits stated in the abstract
- The abstract states that most included systematic reviews were of critically low or low quality and that the meta-analytic evidence was of weak strength, with moderate overlap among reviews.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmcoralhealth.biomedcentral.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Meta-analysis, Oral mucositis, Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.